Author： Goodnick Paul J
Publisher： Informa Healthcare
ISSN： 1474-0338
Source： Expert Opinion on Drug Safety, Vol.4, Iss.4, 2005-07, pp. : 653-668
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Death risk higher with conventional than with atypical antipsychotics
Inpharma, Vol. 1, Iss. 1517, 2005-01 ,pp. :
Access to resources
Recommend
Atypical Antipsychotics for the Treatment of Bipolar Disorder: More Shadows than Lights
CNS Drugs, Vol. 21, Iss. 5, 2007-01 ,pp. :
Atypical antipsychotics: is their higher cost worth it?
Inpharma, Vol. 1, Iss. 1468, 2004-01 ,pp. :
Drug metabolism and atypical antipsychotics
By Prior T.I. Chue P.S. Tibbo P. Baker G.B.
European Neuropsychopharmacology, Vol. 9, Iss. 4, 1999-06 ,pp. :